Literature DB >> 23997348

Biofilm production by Candida: comparison of bloodstream isolates with cervical isolates.

Sheetal U Harakuni1, S G Karadesai, Nadeemaktar Jamadar.   

Abstract

The present study was undertaken to investigate biofilm formation among the clinical Candida isolates from blood and cervical swabs. A total of 16 Candida blood isolates from neonates and 21 cervical isolates from pregnant women with vulvovaginitis were included in the study. Each isolate was identified to species level by various phenotypic tests. Biofilm formation was detected by colorimetric method. C. glabrata and C. albicans were the major isolates from blood and cervical swab respectively. The biofilm formation was found in 14 (87.5 %) blood isolates and only in 4 (19.1 %) cervical isolates.

Entities:  

Keywords:  Biofilm; Blood stream infection; Candida; Vulvovaginitis

Year:  2012        PMID： 23997348      PMCID： PMC3460134          DOI： 10.1007/s12088-012-0261-3

Source DB:  PubMed          Journal:  Indian J Microbiol        ISSN： 0046-8991            Impact factor:   2.461


  17 in total

Review 1.  Candida biofilm: a well-designed protected environment.

Authors:  Pranab K Mukherjee; Guangyin Zhou; Ryan Munyon; Mahmoud A Ghannoum
Journal:  Med Mycol       Date:  2005-05       Impact factor: 4.076

2.  International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program.

Authors:  M A Pfaller; D J Diekema; R N Jones; H S Sader; A C Fluit; R J Hollis; S A Messer
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

Review 3.  Vaginal candidosis: epidemiological and etiological factors.

Authors:  J Ferrer
Journal:  Int J Gynaecol Obstet       Date:  2000-12       Impact factor: 3.561

4.  Biofilm production by isolates of Candida species recovered from nonneutropenic patients: comparison of bloodstream isolates with isolates from other sources.

Authors:  Jong Hee Shin; Seung Jung Kee; Myung Geun Shin; Soo Hyun Kim; Dong Hyeon Shin; Sang Ku Lee; Soon Pal Suh; Dong Wook Ryang
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

Review 5.  Clinical microbiology of bacterial and fungal sepsis in very-low-birth-weight infants.

Authors:  David Kaufman; Karen D Fairchild
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

Review 6.  Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans.

Authors:  P L Fidel; J A Vazquez; J D Sobel
Journal:  Clin Microbiol Rev       Date:  1999-01       Impact factor: 26.132

7.  Biofilm formation in clinical Candida isolates and its association with virulence.

Authors:  Fahmi Hasan; Immaculata Xess; Xiabo Wang; Neena Jain; Bettina C Fries
Journal:  Microbes Infect       Date:  2009-05-04       Impact factor: 2.700

8.  Prevalence & susceptibility to fluconazole of Candida species causing vulvovaginitis.

Authors:  Srujana Mohanty; Immaculata Xess; Fahmi Hasan; Arti Kapil; Suneeta Mittal; Jorge E Tolosa
Journal:  Indian J Med Res       Date:  2007-09       Impact factor: 2.375

9.  Blood stream infections by Candida glabrata and Candida krusei: a single-center experience.

Authors:  Hee Kyoung Choi; Su Jin Jeong; Han Sung Lee; Bum Sik Chin; Suk Hoon Choi; Sang Hoon Han; Myung Soo Kim; Chang Oh Kim; Jun Yong Choi; Young Goo Song; June Myung Kim
Journal:  Korean J Intern Med       Date:  2009-08-26       Impact factor: 2.884

10.  Importance of biofilm in Candida parapsilosis and evaluation of its susceptibility to antifungal agents by colorimetric method.

Authors:  F Růzicka; V Holá; M Votava; R Tejkalová
Journal:  Folia Microbiol (Praha)       Date:  2007       Impact factor: 2.629
View more
  1 in total

1.  A study on biofilm production and antifungal drug resistance among Candida species from vulvovaginal and bloodstream infections.

Authors:  Sanyuktha Tulasidas; Pooja Rao; Sevitha Bhat; Radhakrishna Manipura
Journal:  Infect Drug Resist       Date:  2018-11-23       Impact factor: 4.003
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.